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Background. Although the burden of stroke in terms of mortality and disability has been well documented in previous years, data
after 2000 are limited. Therefore, the aim of this paper was to identify the epidemiology of stroke in the US and EU5 nations from
data published in 2000 and later. Methods. Data from literature databases and online sources were collated to identify information
relating to the incidence, prevalence, and mortality of stroke from the year 2000 onwards. Results and Conclusions. Twenty-three
data sources were identified. The incidence of andmortality due to stroke both increase with age and are greater in males compared
to females. Stroke is a common problem and likely to worsen in the US and EU5 as their populations age. However, pre-2000 trends
of decreasing stroke mortality over time have continued after 2000, reflecting a consistent improvement in the treatment and care
of patients with stroke.
1. Introduction
Strokes, or cerebrovascular accidents as otherwise known, are
a heterogeneous group of conditions that manifest as neuro-
logic deficits occurring due to interruption of the cerebral
blood flow [1]. The causes, outcomes, and treatment strate-
gies diﬀer according to the categories of stroke. It is widely
recognised that strokes are a major cause of adult disability
due to both the debilitating initial symptoms and in many
cases the severe long-term impairment in activities such as
walking and speech [2, 3]. In addition to physical disabilities,
the detrimental eﬀects also extend to significant emotional
burden. Indeed, a large number of stroke survivors are
reported to experience depression [4]. The burden of stroke
is further compounded by substantial economic costs; in the
US, the total cost of stroke for 2008 was estimated to exceed
US$65 billion, while, across the EU countries, the total
annual cost of stroke was estimated to be C27 billion [3].
Several large reviews published in recent years have
documented the burden of stroke in terms of mortality and
morbidity [5–7]. These reviews, however, examined the epi-
demiology of stroke from data collected before 2000. Indeed,
the authors reported that the epidemiology of stroke, as with
the epidemiology of other cardiovascular diseases, may be
changing over time in the populations of developed coun-
tries. This trend for changing epidemiology may be a result
of a number of factors, including an aging population [7] and
advances in the prevention and treatment of stroke [8].
Given the observed changes in the epidemiology of stroke
over time, it is important to obtain a good overview of the
most recent data. To the authors’ knowledge, there are no
published reviews to date examining the epidemiology of
stroke that collate data after 2000 for both the EU and US.
The primary aim of this paper was therefore to identify the
incidence, prevalence, and mortality attributable to stroke
and TIA, based on data collected after 2000. The secondary
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aim of this paper was to determine the trends in the epide-
miology of stroke over time since 2000, as reported in the
included studies.
2. Methods
2.1. Paper Questions. The paper objectives were translated
into the following research questions. (1) What is the inci-
dence, prevalence, and mortality of stroke (and its subtypes)
and TIA, and how does it vary geographically in the EU
and US? (2) How does incidence, prevalence, and mortality
of stroke, its subtypes, and TIA vary with patient character-
istics, specifically age and gender? (3) How has the incidence,
prevalence, and mortality of stroke, subtypes of stroke, and
TIA varied over time geographically?
2.2. Identifying Studies from Literature Databases. A focused
search of the major literature databases MEDLINE Embase
and PubMed was undertaken on the 12th February 2010,
using a structured set of keywords and MeSH terms. The
search strategies developed consisted of terms for stroke
(including for ischaemic stroke, intracerebral haemorrhage,
subarachnoid haemorrhage, and TIA) and for epidemiology
(including for incidence, prevalence, and morality). No re-
strictions on study design were applied to the search strategy;
however, the searches were restricted to articles published
in and after 2000, in order to obtain only the most recent
data. The databases searched were chosen for their wide
coverage of relevant journals and particularly the coverage
of European journals.
Only studies which met or potentially met the following
predefined inclusion criteria were included; epidemiological
studies and reports that provided data on the incidence,
prevalence, or mortality of stroke (of any subtype) or TIA
were included. Literature reviews of epidemiological data
were also included if they contained this information. Studies
were included only if they presented data for one or more
of the countries of interest, namely, the US, UK, France,
Germany, Italy, and Spain. In addition to the publication date
restriction applied to the search strategy (2000 and later),
studies were only included that reported data collected in or
after the year 2000.
Citations identified from literature databases were ini-
tially screened based on the title and abstract provided, to
exclude citations of studies that clearly did not report data
of interest. Full texts were obtained for the citations that
were included after this first screening stage, and these were
screened again based on the contents of their full texts.
Screening was conducted by one reviewer. Only studies clear-
ly meeting the inclusion criteria (as stated above) were in-
cluded at this stage.
2.3. Identifying Studies from Online Searching. In addition to
database searches, extensive online searching was conducted
to identify data published outside of indexed journals. Online
sources searched included country specific websites and
agencies, and government and nongovernment health and
statistics organisations including, but not limited to the
Centers for Disease Control and Prevention (US), British
Heart Foundation (BHF) (UK and Europe), the Information
System of the Federal Health Monitoring (Germany), and
Istituto Nazionale di Statistica (Italy). In line with the studies
included from the literature databases, data were only includ-
ed from the online sources on the incidence, prevalence, or
mortality of stroke or the subtypes of stroke or TIA, which
adhered to the criteria described for the literature databases
sources.
2.4. Data Extraction and Analysis. Data for one study, repor-
ted inmore than one publication or online source, were iden-
tified and linked to prevent double-counting of data. Infor-
mation from each study was extracted by one reviewer and
checked by a second independent reviewer, with any discrep-
ancies resolved following discussion between the reviewers.
Data regarding the incidence, prevalence, and mortality of
stroke and details on the study design and setting were ex-
tracted. Only information relating to the countries of interest
was included. Following extraction, the data were examined
for key trends. No quantitative analyses were conducted to
pool estimates; general trends were described if information
was available from multiple sources.
3. Results
3.1. Trial Flow. Of the 5731 references retrieved by the liter-
ature database search, 34 citations were identified during ini-
tial screening of abstracts as containing data potentially rele-
vant to the paper. Screening of the subsequently sourced full
texts identified 11 published papers meeting the inclusion
criteria; these 11 publications were therefore included in the
current paper. The additional online searching yielded 12
datasets and publications meeting the inclusion criteria.
Of these 23 total data sources, two sources reported data
on French populations, two sources reported data on Ger-
man populations, four sources reported data on Italian pop-
ulations, three sources reported data on Spanish populations,
five sources reported data on UK populations, and five sour-
ces reported data on US populations. Further, one source re-
ported data on several EU5 populations, and another repor-
ted data on several EU5 populations and the US population.
3.2. Morbidity
3.2.1. The Incidence and Prevalence of Stroke (Any Subtype).
Eight studies from five European countries reported the inci-
dence of stroke (any type), Table 1. Most of the studies repor-
ted data for specific regions, with only one study from the
UK providing a nationwide sample [17]. No studies were
identified that compared the incidence of stroke between
diﬀerent countries. Studies report data for diﬀerent coun-
tries, recruit disparate stroke populations (all stroke versus
first stroke only), and vary considerably in the study design
and data collection methods. It is therefore not appropriate
to compare estimates between studies. To this point, studies
conducted in the same country, reporting data by diﬀerent
geographical regions, reported markedly varied incidence
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Table 1: Studies reporting incidence of stroke (any type).
Country Study
Time of
data
collection
Stroke
type
Setting Sample size
Crude incidence in cases per 100 000
per year (95% CI where reported)
Male Female Total
France
Be´jot et al.
2009 [9]
2000–2006
First ever
stroke only
Regional: all inhabitants of
the Dijon region (all ages)
152 606
(69 872
men;
82 734
women)
115.7
(106.3–
125.6)
111.7
(103.2–
120.7)
113.5
(107.2–
120.1)
Germany
FHMS
2008 [10]
2008 All stroke
National: data from
German hospitals on
residents of Germany (all
ages)Strokes classed as
ICD-10 I60–I64
NR 346 354 350
Italy
Corso et
al. 2009
[11]
2004-2005 All stroke
Regional: all inhabitants of
the Valley of Aosta region
(all ages)
123 748
(60 827
men; 62 921
women)
224
(186–261)
223
(186–260)
223
(197–249)
Vega et al.
2009 [12]
2005 All stroke
Regional: inhabitants of the
Castilla y Leon,
Extremadura, and
Coumunitat Valenciana
regions (ages >14 years)
201 205
148
(124–172)
134
(112–157)
141
(125–158)
Spain
Alvaro et
al. 2009
[13]
1998–2003 All stroke
National: incidence of
hospitalisation for stroke,
from the Spanish Ministry
of Health Minimum Basic
Data Set Oﬃce (data for all
ages)
NR NR NR 160
Ferna´ndez
De
Bobadilla
et al. 2008
[14]
2004 All stroke
Incidence of hospital
admissions for stroke for
five centres, in patients
aged >30 years
NR NR NR 220
UK
Rothwell
et al. 2005
[15]
2002–2005
First ever
stroke only
Regional: inhabitants of the
Oxfordshire region (all
ages)
91 106
(46 970
men; 44 136
women)
151 171 161
BHF 2009
[16],
Hippisley-
Cox et al.
2004 [17]
2003 All stroke
National: data from GP
practices across the UK (all
ages)
NR 116 135 NR
US No studies identified
BHF: British Heart Foundation, CI: confidence interval, FHMS: Federal Health Monitoring System, NR: not reported, UK: United Kingdom, US: United
States. Sources: [9–17].
values; for example, estimates from Spain ranged from 141
cases per 100 000 persons per year to 220 cases per 100 000
persons per year [12–14].
Fewer studies (five) reported data on the prevalence of
stroke, Table 2. Data were found for only three countries
(Italy, the UK, and the US), with none comparing prevalence
between diﬀerent countries [16–20]. Comparison across
countries should be performed with caution owing to the
heterogeneity between studies. For example, the 0.15%
prevalence reported in the study from Italy (without strat-
ification by gender) is markedly lower than the prevalence
reported by the studies from the UK and the US (which range
from 1.7% to 2.6% without stratification by gender).
3.2.2. Age and Gender Variations in the Incidence and Preva-
lence of Stroke (Any Subtype). Six of the eight studies pre-
sented in Table 1 compared the crude incidence of stroke
between males and females [9–12, 15, 17]. The data from
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Table 2: Studies reporting prevalence of stroke (any type).
Country Study
Time of
data
collection
Setting Sample size Prevalence in percent (95% CI where reported)
Male Female Total
France No studies identified
Germany No studies identified
Italy
D’Allessandro et
al. 2009 [18]
2004
Inhabitants of the Valley of
Aosta region aged ≥15 years
6930 (3223
men; 3707
women)
1.33
(0.9–1.79)
1.59
(1.24–2.05)
1.47
(1.21–1.78)
Spain No studies identified
2006-2007
Data from registered GP
patients in England, Scotland,
and Wales
61 660 614 NR NR 1.7
2006
Data from the Joint Health
Surveys Unit Health Survey
for England (individuals aged
16 years and over)
NR 2 2 NR
BHF 2009 [16] 2003
Data from the Scottish Health
Survey (individuals aged 16
years and over)
NR 2 2 NR
UK 2005-2006
Data from the Welsh Health
Survey (individuals aged 16
years and over)
NR 3 2 NR
2005-2006
Data from the Northern
Ireland Health and Social
Wellbeing Survey (individuals
aged 16 years and over)
NR 2 1 NR
BHF 2009 [16],
Hippisley-Cox
et al. 2004 [17]
2003
Data from GP practices across
the UK (data from patients of
all ages)
NR 0.7 0.7 NR
US
CDC 2007 [19] 2005
Behavioral Risk Factor
Surveillance System telephone
survey conducted across the
US Participants asked “has a
doctor or other health
professional ever told you that
you had a stroke?”
356 112
(136 201
men;
219 911
women)
2.7
(2.5–2.8)
2.5
(2.4–2.7)
2.6
(2.5–2.7)
CDC 2008 [20] 2008
Behavioral Risk Factor
Surveillance System telephone
survey conducted across the
US Participants asked “ever
told you had a stroke?”
NR NR NR 2.6
BHF: British Heart Foundation, CDC: Centers for Disease Control, CI: confidence interval, NR: not reported, UK: United Kingdom, US: United States.
Sources: [16–20].
France, Germany, Italy, and Spain appear to indicate that
there is no significant diﬀerence between the genders in terms
of the incidence of stroke. However, the data from the UK
studies suggests that the incidence may be higher in females
compared to males. Two of the studies that reported the
crude incidence also calculated incidence age-adjusted to the
standard world and European populations [9, 11]. These
adjusted incidences were observed to be higher inmales com-
pared to females. The study by Corso et al. reported that the
incidence of stroke in males age-adjusted to the New World
Health Organization (WHO) World Standard population
was 122 cases per 100 000 persons per year compared to 77
cases per 100 000 persons per year in females in the Valley of
Aosta in Italy. The study by Bejot et al. reported that the inci-
dence of stroke in males age-adjusted to the European pop-
ulation was 107.5 cases per 100 000 persons per year com-
pared to 68.9 cases per 100 000 persons per year in females in
Dijon in France.
Data showing the relationship between age and gender
on the incidence of stroke were reported by five studies [9,
11, 12, 15, 17]. Four studies (described in three sources) also
presented data on the relationship between age and gender
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on the prevalence of stroke [16, 21, 22]. Both the incidence
and prevalence of stroke increase with age in both genders,
with the incidence in males being generally higher than in
females in the same age group (Figures 1 and 2). This trend
agrees with the age-adjusted data for stroke from France and
Italy [9, 11].
3.2.3. The Incidence and Prevalence of the Diﬀerent Subtypes
of Stroke and TIA. A comparison of incidence rates between
diﬀerent subtypes of stroke is possible, based on the data
reported in five studies (Table 3). Across these studies, it is
apparent that the incidence of ischaemic stroke is much
higher compared to that of haemorrhagic stroke. Further,
where the two subtypes of haemorrhagic stroke are com-
pared, the incidence of intracerebral haemorrhage is higher
than that of subarachnoid haemorrhage.
Two studies compared the incidence of TIA with the sub-
types of stroke [10, 15]; both studies indicated that the inci-
dence of TIA is lower than that of ischaemic stroke but
greater than that of haemorrhagic stroke (Table 3). Addition-
ally, the data suggest that these trends apply in both the male
and female subpopulations and for age-stratified incidence
rates [10, 15].
3.2.4. Age and Gender Variations in the Incidence and Preva-
lence of the Diﬀerent Subtypes of Stroke and TIA. The inci-
dence of ischaemic stroke and TIA, in terms of both first-
time events and all events (overall, and for both genders
independently), generally remains low until the 45 years to 55
years age range is reached, after which the incidence increases
dramatically. The incidence of intracerebral haemorrhage
follows a similar trend (though with much lower incidence).
Of note, however, is that unlike ischaemic stroke and TIA, the
rate of increase in the incidence of intracerebral haemorrhage
with increasing age begins to slow at around the age of 80
years and may even begin to decrease [10, 15].
The relationship between incidence and age is less clear
for subarachnoid haemorrhage. Data from two studies, one
in Germany and the other in the UK, demonstrates that the
incidence of subarachnoid haemorrhage increases with age
until approximately 50 years in both males and females
[10, 15]. Above 50 years of age, the trend in the incidence of
subarachnoid haemorrhage is unclear without any obvious
pattern or relationship. It should also be noted that sub-
arachnoid haemorrhage is the only stroke subtype where the
incidence is much greater in females than in males of the
same age, an observation consistent across all age groups.
3.3. Mortality
3.3.1. The Mortality Rate of Stroke (Any Subtype). Both
the BHF and Organisation for Economic Co-operation and
Development (OECD) studies report that France has the
lowest mortality rate in both males and females across the
EU5 countries (approximately 24 deaths per 100 000 persons
per year to 38 deaths per 100 000 persons per year). These
mortality rates appear comparable with the rates observed
in the US (Figure 3). Italy and the UK demonstrate the
highest rates of stroke-attributable mortality (approximately
41 deaths per 100 000 persons per year to 68 deaths per
100 000 persons per year) [16, 25].
3.3.2. Age and Gender Variations in the Mortality due to Stroke
(Any Subtype). Across all countries, mortality rates are con-
sistently lower in females compared to males (Figure 3).
Further data on the eﬀect of gender on stroke-attributable
mortality were reported by a study conducted in a Scottish
population [26]. This study found that women aged 55 years
to 84 years had lower stroke mortality than men, with the
women-versus-men risk ratios (RRs) varying with age (65
years to 74 years, RR = 0.79 (95% CI: 0.76 to 0.81); 75 years
to 84 years, RR = 0.94 (95% CI: 0.92 to 0.95)). However, the
risk of stroke-attributable death in women aged 85 years or
older is 15% greater compared to men of the same age (RR =
1.15 (95% CI: 1.12 to 1.18)).
Mortality due to stroke is aﬀected by age, with greater
age associated with higher rates of mortality [16]. Few deaths
were observed in the UK in 2007 in those under 35 years of
age (186 deaths); from this age, the absolute number of
deaths increased, from a gradual increase in age groups close
to 35 years to a more rapid increase across the older age
groups. The peak in absolute number of deaths was observed
in those aged 75 years and over (43 649 deaths). Mortality
statistics for the US demonstrated a similar trend [27],
although the peak was reported in those individuals aged 85
years or older since this additional age group was included in
this data set.
The German Federal Health Monitoring System (FHMS)
collected data on the mortality of subtypes of stroke, demon-
strating that, regardless of the subtype, the mortality rate
increased with age [28]. The increase in mortality rate was
greatest for cerebral infarction, while the increase was min-
imal for intracranial haemorrhage.
3.3.3. The Mortality Rates of the Diﬀerent Subtypes of Stroke
and TIA. There is a lack of mortality data relating to the
subtypes of stroke, with data identified for the UK and
US only [16, 27]. Haemorrhagic stroke was reported to be
associated with twice the mortality rate of ischaemic stroke
in both males and females in the UK, despite the incidence
of the latter being greater; mortality rate is 10 deaths per
100 000 population per year for haemorrhagic stroke and 5
deaths per 100 000 population per year for ischaemic stroke
[16]. It is diﬃcult to draw further comparison between
mortality rates of stroke subtypes, owing to the majority of
strokes being classified as “unspecified subtype.”
Similarly, deaths attributable to stroke in the US are rare-
ly reported by stroke subtype. The diﬃculty in comparing
mortality across subtypes is illustrated by the rate of mor-
tality of “stroke, not specified as haemorrhage or infarction”
being 25.1 deaths per 100 000 persons per year, while the rate
is 9.4 deaths per 100 000 persons per year for intracerebral
and other intracranial haemorrhage and less than 3 deaths
per 100 000 persons per year for subarachnoid haemorrhage
and cerebral infarction [27].
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Figure 1: Studies reporting the relationship between the incidence of stroke and age. Incidence reported as cases per 100 000 per year. Darker
shading indicates higher incidence. BHF: British Heart Foundation, UK: United Kingdom. Sources: [9; 11; 12; 15; 16; 17].
 
Figure 2: Studies reporting the relationship between the prevalence of stroke and age. Prevalence reported as percentage. Darker shading
indicates higher prevalence. BHF: British Heart Foundation, NHANES: National Health and Nutrition Examination Survey, NHLBI:
National Heart, Lung, and Blood Institute, SPREAD: Stroke Prevention and Educational Awareness Diﬀusion, UK: United Kingdom, US:
United States. Sources: [16; 21; 22; 23].
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Figure 3: Age-standardised mortality attributable to stroke. BHF: British Heart Foundation, OECD: Organisation for Economic Co-
operation and Development, UK: United Kingdom, US: United States, WHO: World Health Organization. Sources: [16, 25].
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3.4. Trends in Incidence, Prevalence, and Mortality of Stroke
Over Time. The trend in the incidence of stroke over time is
unclear since only two studies were identified reporting
this data, with neither study demonstrating a clear trend
[26, 29]. In one of the studies, which examined data from
the French Dijon Stroke Registry from 1985 to 2006, a very
small, nonsignificant decrease in the incidence of stroke
between the periods 2001–2006 and 1996–2000 in persons
aged 65 years to 80 years was observed [29]. The second
study identified reported the incidence of first stroke-related
hospitalisations in each year between 2000 and 2005 in
Scotland, based on data from the National Health Service
[26]; in this study, a decrease in incidence was observed for
both males and females over the age of 85 years, while no
clear trends were reported for the other age groups. Given
that only these two data sources were identified reporting
incidence rates over time, no firm conclusions can be drawn.
In addition, no studies were identified that examined the
change in incidence over time for any of the subtypes of
stroke and TIA.
The data identified in this paper have indicated that
the prevalence of stroke may be decreasing over time. In
England, the change in the prevalence of stroke between 2003
and 2006 has decreased from 2.7% to 2.4% in males and
from 2.3% to 2.2% in females in individuals aged ≥16 years
[23]. No other study was identified that examined the trend
in prevalence over time for a single population. Further,
no studies were identified that reported the trend in stroke
prevalence stratified by subtype.
Mortality attributable to stroke has decreased over time.
The German FHMS reported that mortality rates for “stroke
not specified as haemorrhage or infarction” in Germany
decreased from 52.4 deaths per 100 000 in 2000 to 32.3 deaths
per 100 000 in 2008 in both males and females combined (a
greater rate of decline was observed for female patients). This
trend is supported by data collected by the BHF from France,
Germany, Italy, and Spain that suggest age-standardised
death rates from stroke have decreased from 2000 to 2006
[16] and further from US data for the same time period that
indicates stroke mortality as defined via ICD-10 codes has
decreased steadily [27, 30]. In addition, UK data demon-
strates that this steady decline in mortality rates is observed
for both subtypes (haemorrhagic and ischaemic stroke) [16];
however, this data should be interpreted with caution owing
to the high proportion of stroke-attributable mortality where
the subtype was not determined.
4. Discussion
The incidence of stroke is considerable across the US and
EU5 countries, with ischaemic stroke and TIAs being the
most common events and therefore presenting the largest
public health burden. Based on the data collected in this
paper, the incidence of stroke in the six countries of interest
ranges between 114 cases per 100 000 persons per year in
France for first ever stroke to 350 cases per 100 000 persons
per year in Germany for all stroke, while prevalence estimates
ranged from 1.5% in Italy and 3% in the UK and US. It is not
appropriate to compare estimates between studies due to the
diﬀerences in study design; however, diﬀerence in incidence
between countries has been reported in previous reviews
[5–7]. Real diﬀerences in the incidence of stroke between
countries would be unsurprising given the varied culture and
lifestyle between countries which in turn results in marked
diﬀerences in exposure to risk factors for stroke that include
smoking, alcoholism, and diet [31].
Perhaps unsurprisingly, given the knowledge that the
risk factors associated with degradation in the functioning
of blood vessels appear, or become exacerbated, with age,
the data identified through this paper demonstrate that the
incidence and prevalence of stroke in general increases with
age. This is true for TIA, ischaemic stroke, and intracerebral
haemorrhage and is also noted in the reviews of pre-2000
data and in cardiovascular diseases in general [6, 7, 21, 30].
It is of note, however, subarachnoid haemorrhagic stroke
does not follow this pattern, showing no clear relationship
between incidence and age. This may be due to the distinct
aetiology of subarachnoid haemorrhages, for which a mech-
anism has yet to be definitively elucidated.
Gender diﬀerences in stroke incidence were also iden-
tified in the paper, with higher estimates of ischaemic and
intracerebral stroke observed in males than females of the
same age, based on age-adjusted data. This supports findings
from the paper of data pre-2000 by Appelros and colleagues
[5], indicating that a shift in incidence has not occurred in
recent years. The incidence of subarachnoid haemorrhagic
stroke is, again, an exception to the trend observed with other
subtypes; incidence is considerably higher in women than in
men of the same age.
Published reviews on the epidemiology of stroke have
not found consistent trends in the incidence of stroke
over time. Some reviews have indicated that incidence has
decreased, some have indicated that incidence has increased,
and others have shown long-term declines to have begun
to reverse in recent years [5, 6]. Our paper was unable to
prove or disprove these previous trends, owing to limited
studies identified that considered this topic [26, 29]. While,
data reported for the English population suggests that the
prevalence of stroke had been increasing from 1994 to 2003,
a decline in prevalence was observed between 2003 and
2006 in both males and females in nearly all age groups
[23]. This may be attributed to recent adoption of modern
preventative treatments such as antiaggregants, statins, and
antihypertensives, which are prescribed to at risk patients to
reduce the risk of cardiovascular and cerebrovascular disease
[31, 32].
Mortality relating to stroke in any population is depen-
dent upon three main factors: (i) the incidence of stroke in
the population, (ii) the quality of medical care available to
individuals who have suﬀered a stroke, and (iii) the preva-
lence of cardiovascular disease and comorbidities that can
aﬀect the likelihood of patients surviving stroke events. The
quality of medical care available both influences the number
of individuals experiencing a stroke and the proportion of
those individuals who die as a result of the stroke experi-
enced. Only one study compared mortality data from the US
to the EU5 and showed that the overall mortality rates for
stroke in the US were similar to those in the EU5, with the
10 Stroke Research and Treatment
stroke-attributable mortality rates for men and women
similar to those of France and Germany, respectively [25].
Of the six countries of interest, the mortality data found in
this paper indicate that France has the lowest mortality due
to stroke.
Stroke-attributable mortality is clearly higher in males
than in females in all six of the countries of interest. This
suggests that women are more likely to survive a stroke when
compared to men. The data also suggest that whilst the like-
lihood of surviving stroke decreases with age in both genders,
the rate of decrease is greater in males compared to females
[33]. The mortality attributed to stroke increases with in-
creasing age, as the risk of a stroke event increases and the
risk of death per event increases [16, 25].
Stroke mortality rates have been decreasing consistently
over time, with recent reports indicating a 29.2% reduction
in stroke mortality between 1999 and 2008 in the US [34].
Indeed, the data suggest that death by stroke has fallen from
the third to the fourth leading cause of death in the US
[35]. This paper supports this and data before 2000, which
suggests that the decline in mortality rates is a continuation
of a trend that has been observed over several decades [6].
Further, given the stable incidence and prevalence estimates
of recent years, the decrease in stroke-attributable mortality
is most likely due to increasing survival after stroke. Such
increased survival may be linked to advancements in treat-
ment and rehabilitation of stroke patients.
Whilst the paper has identified some important trends,
there are several diﬃculties associated in papering the epide-
miology of stroke. Statistics on stroke can often be diﬃcult to
obtain and collect in a standardised or comparable manner.
For example, the BHF report that stroke incidence is usually
recorded from patient admission to hospital, but, from this
data, it is often not possible to determine whether this was
the first stroke or a subsequent stroke. Such classification
then makes it diﬃcult if the stroke should be included in
the incidencemeasures [23]. There is also considerable heter-
ogeneity in the designs of the studies identified, with patient
populations and methods of collecting morbidity data var-
ying between studies and thus potentially introducing diﬀer-
ences in the data reported and conclusions drawn. Both na-
tional and regional data are presented in this paper in order
to provide a comprehensive picture of stroke morbidity,
though it should be noted that studies which investigated
stroke epidemiology at a regional level may not report data
that are representative of the country as a whole. It should
be noted that there is a lack of national data from some
countries; for example, for France there is only regional
data available, which makes comparisons between countries
increasingly diﬃcult.
5. Conclusion
While stroke and TIA remain asmajor clinical burdens across
the US and EU5 countries, the mortality attributable to
stroke continues to decrease over time. The fact that the
trend in decreasing stroke mortality is still being seen in
the data collected after 2000 is encouraging and indicates
that the treatment and rehabilitation of stroke patients have
improved consistently. Therefore, whilst no clear decreases in
incidence or prevalence have been observed and an increase
in burden due to the aging populations of the US and EU5
countries is expected, improvements in the treatment of
patients who suﬀer a stroke may mean that any increase in
the absolute numbers of people experiencing and dying from
stroke will not be as great as it would otherwise be. This
paper has also highlighted the need for additional data on
the epidemiology of stroke, in particular longitudinal studies
that cover the years after 2000.
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